Roche's Taspoglutide Setback Gives Amylin (AMLN) A Boost
Go back to Roche's Taspoglutide Setback Gives Amylin (AMLN) A Boost| Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) | Delayed: 30.98 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.98 | 52 Week High | $31.02 | |||
| Open | $3.30 | 52 Week Low | $8.03 | |||
| Day High | $30.98 | P/E | N/A | |||
| Day Low | $30.98 | EPS | $-4.38 | |||
| Volume | 440,704 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1163.01 -12.4 (1.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1175.41 | 52 Week High | $88.16 | |||
| Open | $1173.91 | 52 Week Low | $67.88 | |||
| Day High | $1175.00 | P/E | 269.22 | |||
| Day Low | $1153.50 | EPS | $4.32 | |||
| Volume | 1,555,531 | |||||
